Showing 1901-1910 of 8891 results for "".
The Women's Dermatologic Society Takes Manhattan
https://practicaldermatology.com/topics/practice-management/the-womens-dermatologic-society-takes-manhattan/20579/WDS leaders educate the media on at-home beauty devices, pigment disorders, and more.Get Ready: The Biosimilars Are Here
https://practicaldermatology.com/topics/psoriasis/get-ready-the-biosimilars-are-here/20662/Recent developments mean that biosimilars are finally hitting the US market.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20905/New Products and Pharmacological Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacological-developments/20429/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/23510/New in My Practice: Rx
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-1/23395/Biologics and Beyond
https://practicaldermatology.com/topics/psoriasis/biologics-and-beyond/23554/A look at off-label use of biologics and JAK inhibitors.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21587/DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with moSCALE 2024: Listen as Dr. Joel Cohen and Dr. Suneel Chilukuri on Microwave Therapy
https://practicaldermatology.com/error/404/Suneel Chilukuri, MD, discusses the various applications of microwave therapy, including non-melanoma skin cancer, with Joel Cohen, MD, at Music City SCALE.